-
Mashup Score: 2
Early progression or death within 24 months of first-line treatment was linked to inferior survival in mantle cell lymphoma.
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 0A Transplant-Free Regimen for Mantle Cell Lymphoma - 2 year(s) ago
By Peter M. GoodwinA study investigating initial treatment that included the Bruton’s tyrosine kinase inhibitor ibrutinib for younger patients with mantle cell lymphoma (MCL) may have opened the door to a transplant-free approach to the disease, according to findings from the Randomized Triangle Trial, conducted by the European MCL Network.“Based on our findings, standard chemotherapy plus…
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet-
A study investigating initial treatment that included the Bruton's tyrosine kinase inhibitor ibrutinib for younger patients with #MantleCellLymphoma may have opened the door to a transplant-free approach to the disease. https://t.co/9wHn9wuLF7 #MCL https://t.co/zVNtsdbisV
-
-
Mashup Score: 0A Transplant-Free Regimen for Mantle Cell Lymphoma - 2 year(s) ago
By Peter M. GoodwinA study investigating initial treatment that included the Bruton’s tyrosine kinase inhibitor ibrutinib for younger patients with mantle cell lymphoma (MCL) may have opened the door to a transplant-free approach to the disease, according to findings from the Randomized Triangle Trial, conducted by the European MCL Network.“Based on our findings, standard chemotherapy plus…
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet-
A study investigating initial treatment that included the Bruton's tyrosine kinase inhibitor ibrutinib for younger patients with #MantleCellLymphoma may have opened the door to a transplant-free approach to the disease. https://t.co/9wHn9wuLF7 #MCL https://t.co/zVNtsdbisV
-
Pooled Analysis Shows POD24 Strongly Predicts Poor Survival in Newly Diagnosed MCL #MantleCellLymphoma #MCL https://t.co/kEAYmUWyWb